Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRUP trial
NL-OMON54670Phase 2Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Aug 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cancer, Nonhematologic neoplasms, multiple myeloma (MM) and 2 more, sponsored by Netherlands Cancer Institute. Primary endpoints: Percentage of patients treated based on their molecular tumor profile, Objective tumor response and 2 more. Started Aug 2016; status: recruiting.
02
Conditions
cancerNonhematologic neoplasmsmultiple myeloma (MM)non-Hodgkin lymphoma (NHL)primary brain neoplasm
Beyond the preview
Go deeper on NL-OMON54670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54670.